Opin vísindi

Contaminated dicloxacillin capsules as the source of an NDM-5/OXA-48-producing Enterobacter hormaechei ST79 outbreak, Denmark and Iceland, 2022 and 2023

Skoða venjulega færslu

dc.contributor.author Agergaard, Charlotte Nielsen
dc.contributor.author Porsbo, Lone Jannok
dc.contributor.author Sydenham, Thomas Vognbjerg
dc.contributor.author Hansen, Sanne Grønvall Kjær
dc.contributor.author Steinke, Kat
dc.contributor.author Larsen, Sanne Løkkegaard
dc.contributor.author Helgason, Kristján Orri
dc.contributor.author Hansen, Frank
dc.contributor.author Karstensen, Kasper Thystrup
dc.contributor.author Henius, Anna E
dc.contributor.author Holzknecht, Barbara Juliane
dc.contributor.author Søes, Lillian
dc.contributor.author Schønning, Kristian
dc.contributor.author Wang, Mikala
dc.contributor.author Ank, Nina
dc.contributor.author Halldórsdóttir, Anna Margrét
dc.contributor.author Guðlaugsson, Ólafur
dc.contributor.author Hammerum, Anette M
dc.contributor.author Kjerulf, Anne
dc.contributor.author Kristensen, Brian
dc.contributor.author Hasman, Henrik
dc.contributor.author Justesen, Ulrik Stenz
dc.date.accessioned 2023-04-25T01:05:40Z
dc.date.available 2023-04-25T01:05:40Z
dc.date.issued 2023-03-02
dc.identifier.citation Agergaard , C N , Porsbo , L J , Sydenham , T V , Hansen , S G K , Steinke , K , Larsen , S L , Helgason , K O , Hansen , F , Karstensen , K T , Henius , A E , Holzknecht , B J , Søes , L , Schønning , K , Wang , M , Ank , N , Halldórsdóttir , A M , Guðlaugsson , Ó , Hammerum , A M , Kjerulf , A , Kristensen , B , Hasman , H & Justesen , U S 2023 , ' Contaminated dicloxacillin capsules as the source of an NDM-5/OXA-48-producing Enterobacter hormaechei ST79 outbreak, Denmark and Iceland, 2022 and 2023 ' , Eurosurveillance , vol. 28 , no. 9 . https://doi.org/10.2807/1560-7917.ES.2023.28.9.2300108
dc.identifier.issn 1560-7917
dc.identifier.other 123509826
dc.identifier.other 94d46255-bd11-4c0e-a9b1-47eda9bc6d0d
dc.identifier.other 36862098
dc.identifier.other PubMedCentral: PMC9983070
dc.identifier.other 85149305071
dc.identifier.other unpaywall: 10.2807/1560-7917.es.2023.28.9.2300108
dc.identifier.uri https://hdl.handle.net/20.500.11815/4162
dc.description Publisher Copyright: © 2023 European Centre for Disease Prevention and Control (ECDC). All rights reserved.
dc.description.abstract From October 2022 through January 2023, nine patients with NDM-5/OXA-48-carbapenemase-producing Enterobacter hormaechei ST79 were detected in Denmark and subsequently one patient in Iceland. There were no nosocomial links between patients, but they had all been treated with dicloxacillin capsules. An NDM-5/OXA-48-carbapenemase-producing E. hormaechei ST79, identical to patient isolates, was cultured from the surface of dicloxacillin capsules in Denmark, strongly implicating them as the source of the outbreak. Special attention is required to detect the outbreak strain in the microbiology laboratory.
dc.format.extent 239386
dc.format.extent
dc.language.iso en
dc.relation.ispartofseries Eurosurveillance; 28(9)
dc.rights info:eu-repo/semantics/openAccess
dc.subject Sýklafræði
dc.subject Smitsjúkdómalæknisfræði
dc.subject Humans
dc.subject Iceland/epidemiology
dc.subject Dicloxacillin
dc.subject Disease Outbreaks
dc.subject Denmark/epidemiology
dc.subject Public Health, Environmental and Occupational Health
dc.subject Epidemiology
dc.subject Virology
dc.title Contaminated dicloxacillin capsules as the source of an NDM-5/OXA-48-producing Enterobacter hormaechei ST79 outbreak, Denmark and Iceland, 2022 and 2023
dc.type /dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article
dc.description.version Peer reviewed
dc.identifier.doi 10.2807/1560-7917.ES.2023.28.9.2300108
dc.relation.url http://www.scopus.com/inward/record.url?scp=85149305071&partnerID=8YFLogxK
dc.contributor.department Other departments


Skrár

Þetta verk birtist í eftirfarandi safni/söfnum:

Skoða venjulega færslu